Ausgabe 4/2013
Inhalt (15 Artikel)
ASCO 2013: news in early-stage and advanced breast cancer
Günther G. Steger, Rupert Bartsch
Recent developments in the palliative treatment of breast cancer: ASCO 2013
Edgar Petru, Tina Idris, Vassilliki Kolovetsiou, Eva Schest
ASCO 2013: new developments in lung cancer
Andreas Pircher, Michael Fiegl, Florian Kocher, Wolfgang Hilbe
ASCO 2013—treatment of metastatic melanoma: is it still a story of success?
Georg Weinlich
Update on neurooncology Annual meeting of the American Society of Clinical Oncology (ASCO) 2013
Silvia Hofer, Christine Marosi
Transfusion-associated graft-versus-host disease: an update
Christian Dal-Pont, Harald Schennach
The contribution of antibodies to targeted cancer therapy
Panagiotis Apostolou, Ioannis Papasotiriou
Targeted delivery of anticancer agents using antibodies as vectors
Maria Toloudi, Ioannis Papasotiriou
Targeting AML with anti-CD33 antibodies: historical walkthrough, clinical impact, future directions
Spyridon Dimitrios Chondropoulos, Annaliza Delastic, Alexandros Spyridonidis
Brentuximab vedotin, a highly active ADC as a new therapeutic option for CD30+ lymphomas
Sofia Stamatopoulou